SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?

To: virginijus poshkus who wrote (360)4/4/1999 10:47:00 PM
From: Sea Otter  Read Replies (2) | Respond to of 550
 
Congratulation Sugen Investors. That was a great piece on
60 minutes. Very balanced, yet positive. I plan on getting
some stock tomorrow.

The new NCI trial for early-state disease: anyone know
the timeframe for this?

And lastly, in case anyone wants to apply some SUGN
gains to other investments, allow me to tout three
other cancer stocks: IMCL, IMGN and GNTA. All have
different science, but promising results.



To: virginijus poshkus who wrote (360)4/4/1999 11:12:00 PM
From: Jeffrey Boggis  Read Replies (2) | Respond to of 550
 
It would not surprise me to see this stock touted as the next Amgen. It would not surprise me to see this stock open between $32-$35 tomorrow. IMHO only. I'm holding 750 shares and should have a nice Monday! :)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News